COVID-19 vaccine rollout management and communication in Europe: one year on

Abstract

Abstract Vaccines represent one of the most important methods to reduce the risk of hospitalisation and mortality as a result of COVID-19. To ensure the spread and risk of the Delta variant of COVID-19 is minimised, as many people as possible nationally must be fully vaccinated. Ensuring success in reaching high rates of vaccination relies on both effective risk management and risk communication strategies. This paper evaluates vaccine rollout management and communication strategies in five European nations: France, Germany, Sweden, Switzerland and England within the UK, updating findings from a previous paper on the same topic from January 2021. This paper evaluates these five nations’ management and communication strategies regarding the vaccine rollout timeline and prioritisation. Further, we discuss the effectiveness and importance of vaccine or immunity passports, highlighting the importance of ensuring that the needs of minoritised groups are considered in promoting the vaccine rollout, and ensuring fairness when prioritising certain groups over others to have earlier access to any vaccine. In conclusion, recommendations for policy makers and public health communicators are put forward.